Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yoshinobu MASUDA
Synthesis and Biological Activity of 11-(4-(Cinnamyl)-1-Piperazinyl)-6,11-Dihydrodibenz(b,e)oxepin Derivatives, Potential Agents for the Treatment of Cerebrovascular Disorders.
Chemical and Pharmaceutical Bulletin
Medicine
Drug Discovery
Chemistry
Related publications
Design, Synthesis and Biological Evaluation of Novel Osthole Derivatives as Potential Agents for the Treatment of Cancer
Biochemistry and Molecular Biology
Synthesis, Reactions and Biological Activity of 11-Azaartemisinin and Derivatives
Arkivoc
Organic Chemistry
Antivertigo Agents. IV. Synthesis and Antivertigo Activity of 6-(.Omega.-(4-Aryl-1-Piperazinyl)alkyl)-5,6,7,8-Tetrahydro-1,6-Naphthyridines.
Chemical and Pharmaceutical Bulletin
Medicine
Drug Discovery
Chemistry
Synthesis, Characterization and Biological Evaluation of Novel 1, 4-Benzodiazepine Derivatives as Potent Anti-Tubercular Agents
Journal of Young Pharmacists
Toxicology
Pharmaceutics
Pharmacology
Synthesis of Cucurbitacin B Derivatives as Potential Anti-Hepatocellular Carcinoma Agents
Molecules
Organic Chemistry
Molecular Medicine
Analytical Chemistry
Theoretical Chemistry
Pharmaceutical Science
Medicine
Drug Discovery
Chemistry
Physical
Synthesis and Biological Evaluation of 3-Arylcoumarin Derivatives as Potential Anti-Diabetic Agents
Journal of Enzyme Inhibition and Medicinal Chemistry
Medicine
Drug Discovery
Pharmacology
Synthesis and Biological Evaluation of Some Novel 2-Phenyl Benzimidazole-1-Acetamide Derivatives as Potential Anthelmintic Agents
Acta Pharmaceutica
Medicine
Pharmacology
Pharmaceutical Science
New Potential Antimalarial Agents: Design, Synthesis and Biological Evaluation of Some Novel Quinoline Derivatives as Antimalarial Agents
Molecules
Organic Chemistry
Molecular Medicine
Analytical Chemistry
Theoretical Chemistry
Pharmaceutical Science
Medicine
Drug Discovery
Chemistry
Physical
Synthesis and Biological Evaluation of (+)-Usnic Acid Derivatives as Potential Anti-Toxoplasma Gondii Agents
